ACACIA RESEARCH (NASDAQ: ACTG) director granted 6,438 shares for Q2 2026 fees
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Molinelli Gavin reported acquisition or exercise transactions in this Form 4 filing.
ACACIA RESEARCH CORP director Gavin Molinelli received 6,438 shares of common stock on June 30, 2026, as a grant in lieu of cash for Q2 2026 director fees. The grant was priced at $4.66 per share and increased his direct holdings to 205,966 shares of common stock. This was a compensation-related share award rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Molinelli Gavin
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, par value $0.001 | 6,438 | $4.66 | $30K |
Holdings After Transaction:
Common Stock, par value $0.001 — 205,966 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Shares granted: 6,438 shares
Grant price: $4.66 per share
Holdings after transaction: 205,966 shares
+2 more
5 metrics
Shares granted
6,438 shares
Common Stock grant on June 30, 2026
Grant price
$4.66 per share
Value used for the Q2 2026 director fee stock grant
Holdings after transaction
205,966 shares
Total direct common stock held by Gavin Molinelli after grant
Transaction code
A
Grant, award, or other acquisition of non-derivative common stock
Transaction direction
acquire
Compensation-related share award, not an open-market purchase
Key Terms
Grant, award, or other acquisition, in lieu of cash, director fees, Common Stock, par value $0.001
4 terms
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
in lieu of cash financial
"Grant of shares of Common Stock in lieu of cash for Q2 2026 director fees."
director fees financial
"in lieu of cash for Q2 2026 director fees."
Common Stock, par value $0.001 financial
"security_title": "Common Stock, par value $0.001""
FAQ
What insider transaction did ACTG director Gavin Molinelli report?
Gavin Molinelli reported receiving a grant of 6,438 ACACIA RESEARCH CORP common shares. The award was compensation, given in stock instead of cash for Q2 2026 director fees, rather than an open-market trade.
Was the ACTG Form 4 transaction a market purchase or sale?
The ACTG Form 4 shows a compensation grant, not a market trade. Shares were issued to Gavin Molinelli in lieu of cash for Q2 2026 director fees, so no open-market buying or selling occurred in this transaction.
What is the purpose of the ACTG stock grant reported for Q2 2026?
The stock grant compensates Gavin Molinelli for Q2 2026 director fees using shares instead of cash. This aligns his compensation partly with equity in ACACIA RESEARCH CORP, as indicated by the footnote describing the award.